Average Co-Inventor Count = 3.97
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merial Limited (8 from 320 patents)
2. Boehringer Ingelheim Animal Health USA Inc. (7 from 82 patents)
3. University of Georgia Research Foundation, Inc. (2 from 842 patents)
4. Other (1 from 832,680 patents)
5. Biolex Therapeutics, Inc. (1 from 16 patents)
6. Sanofi Vaccine Technologies, S.a.s. (1 from 1 patent)
16 patents:
1. 12385068 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof
2. 12280106 - Modified Marek's disease virus, and vaccines made therefrom
3. 11510978 - Modified Marek's disease virus, and vaccines made therefrom
4. 11421249 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof
5. 11058761 - Recombinant vectors expressing antigens of avian influenza virus and uses thereof
6. 10822620 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof
7. 10633667 - Recombinant NDV antigen and uses thereof
8. 10323257 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof
9. 9770502 - Recombinant gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof
10. 9555096 - Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof
11. 9114108 - Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof
12. 9101598 - Recombinant Gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof
13. 9012197 - Production of hemagglutinin-neuraminidase protein in microalgae
14. 8486418 - Recombinant avian paramyxovirus vaccine and method for making and using thereof
15. 8394384 - Recombinant avian influenza vaccine and uses thereof